• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国 COVID-19 病例的中位数年龄下降——是流行病学变化还是监测变化?

Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance?

机构信息

Kaiser Permanente Washington, Renton, Washington, United States of America.

Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.

出版信息

PLoS One. 2020 Oct 15;15(10):e0240783. doi: 10.1371/journal.pone.0240783. eCollection 2020.

DOI:10.1371/journal.pone.0240783
PMID:33057403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7561139/
Abstract

BACKGROUND

Understanding and monitoring the demographics of SARS-CoV-2 infection can inform strategies for prevention. Surveillance monitoring has suggested that the age distribution of people infected with SARS-CoV-2 has changed since the pandemic began, but no formal analysis has been performed.

METHODS

Retrospective review of SARS-CoV-2 molecular testing results from a national reference laboratory was performed. Result distributions by age and positivity were compared between early period (March-April 2020) and late periods (June-July 2020) of the COVID-19 pandemic. Additionally, a sub-analysis compared changing age distributions between inpatients and outpatients.

RESULTS

There were 277,601 test results of which 19320 (7.0%) were positive. The median age of infected people declined over time (p < 0.0005). In March-April, the median age of positive people was 40.8 years (Interquartile range (IQR): 29.0-54.1). In June-July, the median age of positive people was 35.8 years (IQR: 24.0-50.2). The positivity rate of patients under 50 increased from 6.0 to 10.6 percent and the positivity rate for those over 50 decreased from 6.3 to 5.0 percent between the early and late periods. The trend was only observed for outpatient populations.

CONCLUSIONS

We confirm that there is a trend toward decreasing age among persons with laboratory-confirmed SARS-CoV-2 infection, but that these trends seem to be specific to the outpatient population. Overall, this suggests that observed age-related trends are driven by changes in testing patterns rather than true changes in the epidemiology of SARS-CoV-2 infection. This calls for caution in interpretation of routine surveillance data until testing patterns stabilize.

摘要

背景

了解和监测 SARS-CoV-2 感染的人口统计学特征可以为预防策略提供信息。监测监测表明,自大流行开始以来,感染 SARS-CoV-2 的人群的年龄分布发生了变化,但尚未进行正式分析。

方法

对国家参考实验室的 SARS-CoV-2 分子检测结果进行回顾性审查。比较 COVID-19 大流行早期(2020 年 3 月至 4 月)和晚期(2020 年 6 月至 7 月)的年龄和阳性率的结果分布。此外,还进行了一项亚分析,比较了住院患者和门诊患者之间年龄分布的变化。

结果

共检测了 277601 份检测结果,其中阳性结果 19320 份(7.0%)。感染人群的中位年龄随时间推移而降低(p<0.0005)。在 3 月至 4 月期间,阳性人群的中位年龄为 40.8 岁(四分位距(IQR):29.0-54.1)。在 6 月至 7 月期间,阳性人群的中位年龄为 35.8 岁(IQR:24.0-50.2)。50 岁以下患者的阳性率从 6.0%上升到 10.6%,50 岁以上患者的阳性率从 6.3%下降到 5.0%。这种趋势仅在门诊人群中观察到。

结论

我们证实,实验室确诊的 SARS-CoV-2 感染人群的年龄呈下降趋势,但这些趋势似乎仅适用于门诊人群。总体而言,这表明观察到的与年龄相关的趋势是由检测模式的变化而非 SARS-CoV-2 感染的流行病学的真正变化所驱动的。在检测模式稳定之前,应谨慎解释常规监测数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a549/7561139/d6553dad2a58/pone.0240783.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a549/7561139/a7b56170c11d/pone.0240783.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a549/7561139/d6553dad2a58/pone.0240783.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a549/7561139/a7b56170c11d/pone.0240783.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a549/7561139/d6553dad2a58/pone.0240783.g002.jpg

相似文献

1
Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance?美国 COVID-19 病例的中位数年龄下降——是流行病学变化还是监测变化?
PLoS One. 2020 Oct 15;15(10):e0240783. doi: 10.1371/journal.pone.0240783. eCollection 2020.
2
Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.印度对 SARS-CoV-2 的实验室监测:2020 年 1 月 22 日至 4 月 30 日检测的表现和新冠肺炎的描述性流行病学。
Indian J Med Res. 2020 May;151(5):424-437. doi: 10.4103/ijmr.IJMR_1896_20.
3
COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).澳大利亚2019冠状病毒病:流行病学报告18(截至2020年6月7日的两周报告期)
Commun Dis Intell (2018). 2020 Jun 17;44. doi: 10.33321/cdi.2020.44.52.
4
Changing Age Distribution of the COVID-19 Pandemic - United States, May-August 2020.新冠疫情年龄分布变化 - 美国,2020 年 5 月至 8 月。
MMWR Morb Mortal Wkly Rep. 2020 Oct 2;69(39):1404-1409. doi: 10.15585/mmwr.mm6939e1.
5
Spread of SARS-CoV-2 in the Icelandic Population.SARS-CoV-2 在冰岛人群中的传播。
N Engl J Med. 2020 Jun 11;382(24):2302-2315. doi: 10.1056/NEJMoa2006100. Epub 2020 Apr 14.
6
Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020.对两家发生 COVID-19 疫情的熟练护理机构进行的 SARS-CoV-2 连续检测和病毒全基因组测序有助于了解感染风险——明尼苏达州,2020 年 4 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295. doi: 10.15585/mmwr.mm6937a3.
7
COVID-19, Australia: Epidemiology Report 20 (Fortnightly reporting period ending 5 July 2020).澳大利亚2019冠状病毒病:流行病学报告20(截至2020年7月5日的两周报告期)
Commun Dis Intell (2018). 2020 Jul 14;44. doi: 10.33321/cdi.2020.44.63.
8
Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.家长对住院儿童进行 2019 冠状病毒病检测:大流行期间重新思考感染控制。
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):564-565. doi: 10.1093/jpids/piaa103.
9
Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China.中国武汉 5630 例接受 SARS-CoV-2 核酸检测者的特征和诊断率。
JCI Insight. 2020 May 21;5(10):137662. doi: 10.1172/jci.insight.137662.
10
Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.COVID-19 快速监测 - 加利福尼亚州圣克拉拉县,2020 年 3 月。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):419-421. doi: 10.15585/mmwr.mm6914e3.

引用本文的文献

1
Demographic study of patients' mortality rate before and after the COVID-19 outbreak: A cross-sectional study.新冠疫情爆发前后患者死亡率的人口统计学研究:一项横断面研究。
Health Sci Rep. 2024 Feb 8;7(2):e1845. doi: 10.1002/hsr2.1845. eCollection 2024 Feb.
2
Characteristics of cases and deaths arising from SARS-CoV-2 infection in Zambia: March 2020 to April 2021.赞比亚 2020 年 3 月至 2021 年 4 月期间 SARS-CoV-2 感染所致病例和死亡的特征。
Pan Afr Med J. 2023 Aug 10;45:155. doi: 10.11604/pamj.2023.45.155.32018. eCollection 2023.
3
Comparing the incidence of SARS-CoV-2 across age groups considering sampling biases - use of testing data of autumn 2021 in Belgium.

本文引用的文献

1
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
2
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study.加利福尼亚州和华盛顿州严重 2019 冠状病毒病的发病率、临床结局和传播动态:前瞻性队列研究。
BMJ. 2020 May 22;369:m1923. doi: 10.1136/bmj.m1923.
3
Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.
考虑抽样偏差对比不同年龄组的新冠病毒(SARS-CoV-2)发病率——使用比利时2021年秋季的检测数据
Arch Public Health. 2023 Apr 23;81(1):66. doi: 10.1186/s13690-023-01072-9.
4
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review.瑞德西韦治疗 COVID-19 的成本效益及成本与资源使用证据:系统评价。
Infection. 2023 Apr;51(2):285-303. doi: 10.1007/s15010-022-01930-8. Epub 2022 Oct 12.
5
Population vitamin D status might be related to COVID-19 mortality but not with infection rate in Africa: evidence from ecological analysis.人群维生素 D 状况可能与 COVID-19 死亡率有关,但与非洲的感染率无关:来自生态学分析的证据。
Pan Afr Med J. 2022 Mar 25;41:249. doi: 10.11604/pamj.2022.41.249.29619. eCollection 2022.
6
Disaggregated data on age and sex for the first 250 days of the COVID-19 pandemic in Bucharest, Romania.罗马尼亚布加勒斯特 COVID-19 大流行头 250 天的年龄和性别分类数据。
Sci Data. 2022 May 31;9(1):253. doi: 10.1038/s41597-022-01374-7.
7
Longitudinal validation of an electronic health record delirium prediction model applied at admission in COVID-19 patients.电子病历谵妄预测模型在 COVID-19 患者入院时的纵向验证。
Gen Hosp Psychiatry. 2022 Jan-Feb;74:9-17. doi: 10.1016/j.genhosppsych.2021.10.005. Epub 2021 Nov 2.
8
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy.COVID-19 临床表型和短期结局:意大利疫情第一波和第二波的差异。
Expert Rev Respir Med. 2021 Dec;15(12):1619-1625. doi: 10.1080/17476348.2021.1960824. Epub 2021 Aug 18.
9
Performance of a SARS-CoV-2 antigen rapid immunoassay in patients admitted to the emergency department.急诊科患者中 SARS-CoV-2 抗原快速免疫测定的性能。
Int J Infect Dis. 2021 Sep;110:135-140. doi: 10.1016/j.ijid.2021.07.043. Epub 2021 Jul 22.
10
Global Temporal Patterns of Age Group and Sex Distributions of COVID-19.新冠病毒病年龄组和性别分布的全球时间模式
Infect Dis Rep. 2021 Jun 21;13(2):582-596. doi: 10.3390/idr13020054.
加利福尼亚州综合医疗保健系统中 COVID-19 住院成人的特征。
JAMA. 2020 Jun 2;323(21):2195-2198. doi: 10.1001/jama.2020.7202.
4
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
5
Covid-19 worldwide: we need precise data by age group and sex urgently.全球新冠疫情:我们急需按年龄组和性别划分的精确数据。
BMJ. 2020 Apr 3;369:m1366. doi: 10.1136/bmj.m1366.
6
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘,用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.